Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance. 1989

H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.

We report the immunohistochemical detection of the 170-180 kDa multi-drug-resistance-related P-glycoprotein in human tumor cells with a low level of resistance. A series of human squamous lung cancer cell lines with increasing levels of resistance to doxorubicin (DOX) was developed and stained for P-glycoprotein, using the JSB-IMAb. Subline SW1573/50A with a 4- to 6-fold cross-resistance to daunorubicin (DNR) and vincristine (VCR) showed rather uniform positive staining for P-glycoprotein apparently at cytoplasmic sites. Only in cells with higher degrees of resistance (greater than 10-fold) could plasma-membrane-associated P-glycoprotein be made visible. DNR efflux was increased in SW1573/50A as compared to the parent line SW1573 (52 and 70% DNR were retained during 3 min efflux respectively). Verapamil partially reversed DNR and VCR resistance in SW1573/50A. Cells obtained from a metastasized renal cell carcinoma and cultured in vitro stained in a similar way to SW1573/50A and showed some sensitivity to verapamil modulation of VCR cytotoxicity. Our results suggest that weakly resistant cancer cells obtained from patients can be routinely detected with JSB-I on cytospins, and implicate that in such weakly resistant cells P-glycoprotein may be present, while plasma membrane expression is not yet readily detectable.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
August 1990, British journal of cancer,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
January 1990, Nouvelle revue francaise d'hematologie,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
January 1990, European urology,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
April 2008, Acta pharmacologica Sinica,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
January 2018, International journal of medical sciences,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
January 1991, Journal of the National Cancer Institute,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
December 2002, Current protein & peptide science,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
March 1992, American journal of obstetrics and gynecology,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
April 1991, The American journal of pathology,
H J Broxterman, and H M Pinedo, and C M Kuiper, and J J van der Hoeven, and P de Lange, and J J Quak, and R J Scheper, and H G Keizer, and G J Schuurhuis, and J Lankelma
December 1987, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!